3i Group, a British multinational private equity and venture capital, completed the acquisition of Sani-Tech West, a US-based manufacturer, distributor and integrator of single-use bioprocessing systems and components. Financial terms were not disclosed. “We are excited to partner with Richard and his team, who have built a US market leader in single-use solutions for the biopharma industry. This represents a transformational combination for both companies, delivering immediate scale and global reach and enhancing our combined product offerings, capabilities and ability to serve our customers,” Richard Relyea, 3i Partner.